Skip to main navigation
logo
Investors
  • News Archive
  • Past Events and Presentations
  • Stock History

News Archive

News Archive

Sep 21, 2012
Mylan Launches Generic Version of Antivert® Tablets, 12.5 mg, 25 mg and 50 mg
Sep 07, 2012
Mylan Announces Settlement Agreement in Litigation Relating to Detrol® LA
Sep 06, 2012
Mylan Launches First Ever App of Its Generic Brand Reference® Guide
Sep 04, 2012
Mylan Selected as a Leading ARV Supplier to India's National AIDS Control Organization
Aug 22, 2012
Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
Aug 17, 2012
Mylan Launches Generic Actoplus Met® Tablets and Generic Actos® Tablets
Aug 14, 2012
Mylan Specialty Offers Free EpiPen® (epinephrine) Auto-Injectors to Schools Nationwide
Aug 10, 2012
Mylan Launches Lithium Carbonate Extended-Release Tablets USP
Aug 10, 2012
Mylan Launches Generic Version of Provigil® Tablets
Aug 07, 2012
Mylan Specialty and Pfizer Announce Licensing Agreement for EpiPen® Injection 0.3/0.15mg in Japan

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • Current page 61
  • Page 62
  • Page 63
  • Page 64
  • Page 65
  • …
  • Next page next ›
  • Last page last »
Share

Utility Nav

  • Privacy Statement
  • Terms and Conditions
©2026 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.
mylan